vs
MATERION Corp（MTRN）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是MATERION Corp的1.1倍（$622.0M vs $549.8M），Royalty Pharma plc净利率更高（34.4% vs 3.5%，领先30.9%），MATERION Corp同比增速更快（30.8% vs 4.8%），过去两年MATERION Corp的营收复合增速更高（13.6% vs 4.6%）
Materion是一家专注于高性能先进材料领域的跨国企业，核心产品涵盖先进铍金属、薄膜沉积材料、高性能合金及复合材料、特种工程铍、工程金属、工业陶瓷、钽、铌等各类贵金属与非贵金属，同时提供无机化学品及特种涂层解决方案，广泛应用于高端制造领域。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MTRN vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.1倍
$549.8M
营收增速更快
MTRN
高出26.0%
4.8%
净利率更高
RPRX
高出30.9%
3.5%
两年增速更快
MTRN
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $549.8M | $622.0M |
| 净利润 | $19.4M | $214.2M |
| 毛利率 | 14.9% | — |
| 营业利润率 | 5.1% | 62.4% |
| 净利率 | 3.5% | 34.4% |
| 营收同比 | 30.8% | 4.8% |
| 净利润同比 | 9.5% | 2.9% |
| 每股收益（稀释后） | — | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MTRNRPRX
| Q1 26 | $549.8M | — | ||
| Q4 25 | $489.8M | $622.0M | ||
| Q3 25 | $444.8M | $609.3M | ||
| Q2 25 | $431.7M | $578.7M | ||
| Q1 25 | $420.3M | $568.2M | ||
| Q4 24 | $436.9M | $593.6M | ||
| Q3 24 | $436.7M | $564.7M | ||
| Q2 24 | $425.9M | $537.3M |
净利润MTRNRPRX
| Q1 26 | $19.4M | — | ||
| Q4 25 | $6.6M | $214.2M | ||
| Q3 25 | $25.4M | $288.2M | ||
| Q2 25 | $25.1M | $30.2M | ||
| Q1 25 | $17.7M | $238.3M | ||
| Q4 24 | $-48.9M | $208.2M | ||
| Q3 24 | $22.3M | $544.0M | ||
| Q2 24 | $19.0M | $102.0M |
毛利率MTRNRPRX
| Q1 26 | 14.9% | — | ||
| Q4 25 | 13.0% | — | ||
| Q3 25 | 19.4% | — | ||
| Q2 25 | 19.1% | — | ||
| Q1 25 | 18.1% | — | ||
| Q4 24 | 21.3% | — | ||
| Q3 24 | 18.5% | — | ||
| Q2 24 | 19.0% | — |
营业利润率MTRNRPRX
| Q1 26 | 5.1% | — | ||
| Q4 25 | 2.2% | 62.4% | ||
| Q3 25 | 7.9% | 70.1% | ||
| Q2 25 | 8.5% | 36.3% | ||
| Q1 25 | 6.5% | 94.0% | ||
| Q4 24 | -8.8% | 60.9% | ||
| Q3 24 | 7.2% | — | ||
| Q2 24 | 7.5% | 50.2% |
净利率MTRNRPRX
| Q1 26 | 3.5% | — | ||
| Q4 25 | 1.3% | 34.4% | ||
| Q3 25 | 5.7% | 47.3% | ||
| Q2 25 | 5.8% | 5.2% | ||
| Q1 25 | 4.2% | 41.9% | ||
| Q4 24 | -11.2% | 35.1% | ||
| Q3 24 | 5.1% | 96.3% | ||
| Q2 24 | 4.5% | 19.0% |
每股收益（稀释后）MTRNRPRX
| Q1 26 | — | — | ||
| Q4 25 | $0.30 | $0.49 | ||
| Q3 25 | $1.22 | $0.67 | ||
| Q2 25 | $1.21 | $0.07 | ||
| Q1 25 | $0.85 | $0.55 | ||
| Q4 24 | $-2.34 | $0.46 | ||
| Q3 24 | $1.07 | $1.21 | ||
| Q2 24 | $0.91 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $16.2M | $618.7M |
| 总债务越低越好 | $489.9M | $9.0B |
| 股东权益账面价值 | $957.0M | $9.7B |
| 总资产 | $1.9B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.51× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MTRNRPRX
| Q1 26 | $16.2M | — | ||
| Q4 25 | $13.7M | $618.7M | ||
| Q3 25 | $16.4M | $938.9M | ||
| Q2 25 | $12.6M | $631.9M | ||
| Q1 25 | $15.6M | $1.1B | ||
| Q4 24 | $16.7M | $929.0M | ||
| Q3 24 | $17.9M | $950.1M | ||
| Q2 24 | $17.1M | $1.8B |
总债务MTRNRPRX
| Q1 26 | $489.9M | — | ||
| Q4 25 | $460.6M | $9.0B | ||
| Q3 25 | $458.9M | $8.9B | ||
| Q2 25 | $427.6M | $8.0B | ||
| Q1 25 | $453.0M | $7.6B | ||
| Q4 24 | $443.9M | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益MTRNRPRX
| Q1 26 | $957.0M | — | ||
| Q4 25 | $943.3M | $9.7B | ||
| Q3 25 | $934.6M | $9.6B | ||
| Q2 25 | $910.6M | $9.5B | ||
| Q1 25 | $887.9M | $9.8B | ||
| Q4 24 | $868.9M | $10.3B | ||
| Q3 24 | $931.9M | $10.3B | ||
| Q2 24 | $907.1M | $9.8B |
总资产MTRNRPRX
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.8B | $19.6B | ||
| Q3 25 | $1.8B | $19.3B | ||
| Q2 25 | $1.7B | $18.3B | ||
| Q1 25 | $1.8B | $17.6B | ||
| Q4 24 | $1.7B | $18.2B | ||
| Q3 24 | $1.9B | $18.0B | ||
| Q2 24 | $1.8B | $17.7B |
负债/权益比MTRNRPRX
| Q1 26 | 0.51× | — | ||
| Q4 25 | 0.49× | 0.92× | ||
| Q3 25 | 0.49× | 0.93× | ||
| Q2 25 | 0.47× | 0.84× | ||
| Q1 25 | 0.51× | 0.78× | ||
| Q4 24 | 0.51× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MTRNRPRX
| Q1 26 | — | — | ||
| Q4 25 | $19.5M | $827.1M | ||
| Q3 25 | $18.3M | $702.6M | ||
| Q2 25 | $49.9M | $364.0M | ||
| Q1 25 | $15.5M | $596.1M | ||
| Q4 24 | $76.3M | $742.5M | ||
| Q3 24 | $5.1M | $703.6M | ||
| Q2 24 | $20.3M | $658.2M |
自由现金流MTRNRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-24.3M | — | ||
| Q2 24 | — | — |
自由现金流率MTRNRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -5.6% | — | ||
| Q2 24 | — | — |
资本支出强度MTRNRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | — | — |
现金转化率MTRNRPRX
| Q1 26 | — | — | ||
| Q4 25 | 2.97× | 3.86× | ||
| Q3 25 | 0.72× | 2.44× | ||
| Q2 25 | 1.99× | 12.06× | ||
| Q1 25 | 0.88× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 0.23× | 1.29× | ||
| Q2 24 | 1.07× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MTRN
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
